Beam Therapeutics Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
November 08, 2023 at 07:31 am EST
Beam Therapeutics Inc. reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported net loss was USD 96.09 million compared to USD 109.58 million a year ago. Basic loss per share from continuing operations was USD 1.22 compared to USD 1.56 a year ago.
For the nine months, net loss was USD 275.32 million compared to USD 250.74 million a year ago. Basic loss per share from continuing operations was USD 3.63 compared to USD 3.59 a year ago.